Skip to content
Artwork for AACE Podcasts

AACE Podcasts

AACE

Welcome to AACE podcasts! Tune in as we elevate clinical endocrinology by taking deep dives into trends and topics that can help us improve our patient care and global health. Created by clinical endocrine experts for healthcare professionals. Topics include thyroid, diabetes, obesity, adrenal, and more. Find the latest episodes on AACE.com/podcasts. Copyright American Association of Clinical Endocrinology. 

Play
  • 20 episodes
  • Avg 28 min
  • English
  • July 6 · 18 min

    Episode 77: Endocrine Practice Endocrine Legends Series: Dr. Guillermo E. Umpierrez

    Join endocrine expert and Endocrine Practice Associate Editor, Dr. Cecilia M. Lansang, as she interviews Dr. Guillermo E. Umpierrez, professor of medicine at Emory University School of Medicine, clinician educator and researcher, for a candid conversation about his journey in medicine, endocrinology, and inpatient diabetes care. Dr. Umpierrez reflects on his early work studying diabetic ketoacidosis and ketosis-prone diabetes, the mentors and teams who shaped his academic career, and the importance of finding the right environment, enjoying the work and celebrating small successes along the way. To learn more, read Dr. Umpierrez’s review article in Endocrine Practice: Ketosis-Prone Type 2 Diabetes Mellitus: 3 Decades of Clinical, Pathophysiologic, and Therapeutic Insights.

  • May 28 · 24 min

    Episode 76: Endocrine Practice Endocrine Legends Series: Dr. David M. Nathan

    Join endocrine expert and Endocrine Practice Associate Editor, Dr. Melissa Putman as she interviews renowned endocrinologist and diabetes researcher Dr. David Nathan for a candid and inspiring conversation reflecting on more than five decades of groundbreaking work in diabetes research and patient care. Together, they discuss Dr. Nathan’s remarkable career, including his work on the DCCT, diabetes prevention, and early GLP studies, while also exploring the future of diabetes research and advice for the next generation of researchers. To learn more, read Dr. Nathan’s review article in Endocrine Practice: Goodbye to All That? Personal Reflections on 50 years of Diabetes Research: Right Time, Right Place, Great Colleagues and Unwavering NIH Support.

  • April 30 · 30 min

    Episode 75: AACE Journey for Patients With Obesity - Patient Perspective

    Join endocrinologist Elizabeth Bauer, MD, FACP, FACE, DABOM, as she speaks with Michelle about her experience living with obesity, including the challenges, stigma, and turning points that shaped her path. Together, they explore the AACE Journey for Patients With Obesity, as Michelle shares which parts she found most helpful for understanding obesity as a chronic disease and navigating next steps. Don’t miss this inspiring discussion, brought to you with the support of Boehringer-Ingelheim, Lilly, Novo Nordisk, and Amgen.

  • April 14 · 35 min

    Episode 74: 2026 AACE Algorithm for Management of Adults with Type 2 Diabetes: Key Updates and Clinical Insights

    Join endocrine expert Vin Tangpricha, MD, PhD, as he moderates a discussion with members of the task force behind the updated 2026 AACE Consensus Statement: Algorithm for the Management of Adults with Type 2 Diabetes. AACE Past President and Chair Susan L. Samson, MD, PhD, FRCPC, FACE, is joined by Vice Chair Priyathama Vellanki, MD, along with Lawrence Blonde, MD, FACP, MACE, and Irl B. Hirsch, MD, MACP, to discuss key changes. Together, they explore how the new algorithm supports more individualized, complications-focused care and provides practical guidance clinicians can apply in everyday practice.

  • Dec 11, 2025 · 24 min

    Episode 73: Understanding Hypophosphatemia: Recognition, Diagnosis, and Treatment

    Join Dr. Steven Petak, Past President of AACE and ISCD and former Chief of Endocrinology at Houston Methodist Hospital, as he leads an in-depth conversation on Hypophosphatemia with Dr. Laila Tabatabai, Associate Professor of Clinical Medicine at Weill Cornell and metabolic bone specialist at Houston Methodist, and Dr. Basma Abdulhadi, Assistant Professor of Medicine at the University of Alabama at Birmingham and head of bone densitometry. Together, they discuss how to distinguish Hypophosphatemia from osteoporosis and osteomalacia, recognize key symptoms across ages, and apply a focused diagnostic workup. The discussion also highlights FGF23-mediated disorders, XLH, and current treatment approaches including burosumab, reinforcing a key reminder for clinicians to check phosphate levels to help prevent missed diagnoses. This episode is made possible through a sponsorship from Kyowa Kirin. Kyowa Kirin was not involved in the content of the podcast.

  • Dec 5, 2025 · 20 min

    Episode 72: Recognizing non-neoplastic hypercortisolism

    Join Dr. Bahar Force, Endocrinologist, Medical Director of the Pituitary Center, and Associate Program Director of the Endocrinology Fellowship Program at Baylor College of Medicine, as she speaks with leading experts Dr. James Findling, Clinical Professor of Endocrinology at the Medical College of Wisconsin, and Dr. Ty Carroll, Visiting Professor of Endocrinology and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Wisconsin Madison, for a clinician-focused conversation on non-neoplastic hypercortisolism. Together, they discuss how common conditions can lead to cortisol elevations that resemble Cushing syndrome, the clinical patterns that raise concern for neoplastic hypercortisolism, and the growing role of the Desmopressin Stimulation Test in helping distinguish between the two. The episode also highlights emerging research, including insights from the Catalyst study and the potential role of cortisol-directed therapy.

  • Nov 5, 2025 · 28 min

    Episode 71: 2025 Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease Overview

    Join endocrine expert Dr. David Lieb as he moderates a discussion with Dr. Karl Nadolsky, Chair of the AACE Obesity Algorithm, and Dr. Timothy Garvey, Vice Chair, as they review the 2025 AACE Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease and highlight key updates since 2016. The experts discuss advances in pharmacotherapy, the evolution of complication-centric and person-centered care, and strategies to reduce weight bias in clinical practice. They also share guidance on individualizing therapy and look ahead to the future of obesity medications as new treatments emerge.

  • Oct 20, 2025 · 26 min

    Episode 70: 2025 Algorithm for Management of Adults with Dyslipidemia Update Overview

    Join endocrine expert Dr. David Lieb as he moderates a discussion with Dr. Shailendra Patel, Chair of the 2025 AACE Dyslipidemia Algorithm; Dr. Maria Belalcazar, Vice Chair; and Dr. Robert Hegele, Author and Representative of the Canadian Cardiovascular Society, about the 2025 Updated Algorithm for Management of Adults with Dyslipidemia. This episode covers: The rationale behind updating the algorithm and how it aligns with the 2025 Clinical Practice Guideline for the Pharmacologic Management of Adults with Dyslipidemia Key updates from the 2020 algorithm, including expanded guidance on hypertriglyceridemia and lipid management in special populations Practical strategies for integrating the algorithm into everyday clinical practice and medical education with an emphasis on patient-centered care, shared decision making, and health equity Emerging therapies on the horizon and priority areas for future research Tune in to hear expert insights on how this updated, evidence-based resource can support better clinical decision making and improve patient outcomes.

  • Oct 17, 2025 · 22 min

    Episode 69: Expanding Access to Continuous Glucose Monitoring in Medicare Patients Receiving Specialty Diabetes Care: A Quality Improvement Project

    Join Dr. Cecilia Lansang, Associate Editor of Endocrine Practice, Professor of Medicine, and Director of Endocrinology at Cleveland Clinic, as she speaks with Dr. Kristen Flint, Interim Director of Quality and Safety for Endocrinology at Massachusetts General Hospital, Attending Endocrinologist at MGH, and Instructor at Harvard Medical School, about her team’s quality improvement project, “Expanding Access to Continuous Glucose Monitoring in Medicare Patients Receiving Specialty Diabetes Care.” This episode covers: Strategies for implementing quality improvement interventions in a large academic diabetes specialty clinic Key interventions that increased CGM utilization, including targeted provider education, workflow optimization, and patient outreach Lessons for advancing equitable implementation and sustaining quality improvement over time Tune in for practical insights on bridging policy changes and clinical practice to improve CGM access for Medicare patients. Read the full article in the August 2025 issue of Endocrine Practice here.

  • Sep 29, 2025 · 28 min

    Episode 68: Impulse Control Disorders in Patients with Hyperprolactinemia on Dopamine Agonist Therapy

    Join Elizabeth M. Bauer, MD, FACP, FACE, Dipl ABOM, as she interviews Nicholas A. Tritos, MD, DSc, Professor of Clinical Medicine at Harvard Medical School and faculty of the Neuroendocrine Unit/Neuroendocrine and Pituitary Tumor Clinical Center at Massachusetts General Hospital, about his Endocrine Practice article, Impulse Control Disorders in Patients with Hyperprolactinemia on Dopamine Agonist Therapy – How Concerned Should We Be? The conversation explores the prevalence and risk factors for impulse control disorders, underlying biological mechanisms, clinical screening strategies, and approaches to patient counseling and management. Read the full article in the July 2025 issue of Endocrine Practice here: https://doi.org/10.1016/j.eprac.2025.04.018

  • Sep 29, 2025 · 50 min

    Episode 67: Obstructive Sleep Apnea – Screening and Treatment Updates

    Join leading experts Fariha Abbasi-Feinberg, MD, FAASM, Medical Director of Sleep Medicine at Millennium Physician Group and President Elect for the American Academy of Sleep Medicine; Inderpreet K. Madahar, MD, MBBS, Assistant Professor of Endocrinology, Diabetes, and Metabolism at Corewell Health; and Sarah Nadeem, MD, FACE, Assistant Professor, Section of Endocrinology, Diabetes, and Metabolism at Baylor College of Medicine, Houston, TX, as they discuss the complex relationship between obstructive and central sleep apnea and metabolic disorders such as obesity and type 2 diabetes. Key topics include: Who should be screened for sleep apnea and the recommended screening tools First-line and adjunctive therapies for management The evolving role of multidisciplinary care How clinical practice is shifting with the recent FDA label expansion of tirzepatide (Zepbound®) When tirzepatide may be considered alongside or in place of CPAP, APAP, and BiPAP therapies Tune in for practical insights to better identify, manage, and support patients at risk. This episode is made possible through a sponsorship from Lilly.

  • Jul 16, 2025 · 50 min

    Episode 66: Bone Health Optimization with Food and Fitness

    Join Dr. Laila Tabatabai, Chair of the AACE Bone and Parathyroid Disease State Network, for an expert-led discussion on how nutrition and exercise support bone health. She is joined by Dr. Deborah Sellmeyer, an internationally recognized endocrine expert in metabolic bone disease at Stanford University, and Rebekah Rotstein, founder of the Buff Bones® exercise system. Together, they explore: How much calcium and vitamin D are needed for bone health The benefits of weight-bearing, resistance, balance, and impact exercises Supplements that support bone health, including vitamin K, magnesium, boron, and strontium, along with the potential benefits of prunes The growing role of muscle strength, sarcopenia, and protein in osteoporosis care Whether you are a clinician or someone managing osteoporosis, this episode offers practical, evidence-based insights to help guide informed decisions.

  • Jun 27, 2025 · 20 min

    Episode 65: AACE Patient Journey of Diabetes Technology

    Join clinical experts Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNU, Madhuri M. Vasudevan, MD, MPH, FACE, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, to learn how the AACE Patient Journey of Diabetes Technology supports people with diabetes in navigating their treatment options with confidence. This patient-friendly resource, developed from AACE clinical guidelines and reviewed by Diabetes Sisters, a leading patient advocacy organization, provides clear and accurate information on diabetes technologies, from glucose monitors to insulin delivery devices. The experts also highlight how members of the endocrine care team are using this tool to empower people with diabetes to manage their journey. This episode is brought to you with the support of Abbott, Novo Nordisk, Minimed, and Vertex.

  • Jun 2, 2025 · 24 min

    Episode 64: Meet the Endocrine Care Team – A Collaborative Approach to Patient Care

    Join AACE Past President and endocrinologist Dr. Susan Samson as she leads a compelling roundtable discussion highlighting the importance of the endocrine care team model. She is joined by nurse practitioner Dominique Uva, physician associate Sonia Bahroo, nurse scientist and diabetes educator Dr. Julia Blanchette, endocrine pharmacist Dr. Diana Isaacs, and nurse practitioner and clinical professor Dr. Chris Yedinak. Together, they explore how multidisciplinary care teams are essential to addressing the growing burden of endocrine diseases such as diabetes and thyroid disorders. Each expert shares how they collaborate across disciplines to improve access, provide patient support, and extend specialist care, especially in underserved communities. Tune in for practical insights, collaborative strategies, and a deeper look into how team-based care can elevate endocrine health outcomes.

  • May 23, 2025 · 21 min

    Episode 63: Redefining Obesity - Discussions on the Lancet Commission

    In this episode, Dr. Jaime Almandoz, Associate Professor of Medicine at UT Southwestern, is joined by Dr. Robert F. Kushner, Professor of Medicine at Northwestern University and a leading authority in obesity medicine, to discuss the recent Lancet Diabetes & Endocrinology Commission report, “Definition and Diagnostic Criteria of Clinical Obesity.” The report introduces a new framework for defining clinical and preclinical obesity, aiming to move beyond the limitations of BMI. Dr. Kushner shares insights into the Commission’s global consensus process and how the updated definitions can transform care, reduce weight stigma, and support more targeted treatment. Don’t miss this timely conversation on the evolving future of obesity diagnosis and management.

  • May 5, 2025 · 11 min

    Episode 62: Topic Interest Groups and 2025 Annual Meeting

    Join 2025 Annual Meeting Chair, Cecilia Low Wang, MD, FACP, FACE, as she interviews Rachna Relwani, MD, Chair of the Environmental Endocrinology Topic Interest Group (TIG), and David C. Lieb, MD, FACP, FACE, Chair of the Artificial Intelligence and Clinical Endocrinology TIG. In this episode, you'll gain insight into how these TIGs are advancing critical conversations, fostering collaboration through AACE’s new Facebook Groups, and preparing for engaging meetups at the AACE Annual Meeting in Orlando, May 15–17. Whether you're passionate about environmental health or curious about the role of AI in clinical practice, this episode offers a dynamic preview of what’s ahead.

  • Apr 22, 2025 · 32 min

    Episode 61: Practical Applications of Automated Insulin Delivery Systems in the Management of Diabetes Mellitus

    Join endocrine experts Lubaina S. Presswala, DO, FACOI, FACE; Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, FADCES; and Viral N. Shah, MD, FACE, as they explore the latest in continuous glucose monitors (CGMs) and automated insulin delivery (AID) systems for managing diabetes. In this episode, they discuss the practical applications of diabetes technology, patient selection, shared decision-making, and considerations for device use in specific populations, including athletes and pregnant individuals. This conversation provides valuable insights to help clinicians navigate device options and enhance outcomes across diverse patient scenarios.

  • Apr 15, 2025 · 22 min

    Episode 60: 2025 AACE MEN1 Consensus Statement Overview

    Join Dr. David Lieb as he moderates a discussion with Dr. Jaydira Del Rivero, Chair of the MEN1 Consensus Statement Task Force, and Dr. Michelle Lundholm, Methodology Fellow, about the recently released 2025 AACE Consensus Statement on the Management of Multiple Endocrine Neoplasia, Type 1 (MEN1). This episode covers: AACE’s updated consensus statement methodology, including the new methodology fellow and patient representative roles The role of surgical and non-surgical management strategies for patients with different types of MEN1-related tumors The importance of patient values and preferences and risks/benefits of different screening modalities when determining appropriate screening frequencies for patients Current gaps in the literature and future considerations for MEN1 research

  • Mar 3, 2025 · 32 min

    Episode 59: Early Detection of Type 1 Diabetes

    Early detection and monitoring of Type 1 Diabetes (T1D) are crucial for improving patient outcomes and quality of life. Join clinical experts Lubaina S. Presswala, DO, FACOI, FACE; Jeff Unger, MD, FAAFP, FACE, DACD; and Javier Morales, MD, FACP, FACE, as they discuss the growing prevalence of T1D, the importance of autoantibody screening, the different stages of T1D, screening guidelines, patient counseling, and how early intervention can help delay progression and reduce complications. Support for this podcast is provided by Sanofi.

  • Feb 5, 2025 · 42 min

    Episode 58: 2025 AACE Dyslipidemia Guideline Methodology

    In this episode, join moderator Dr. David Lieb alongside esteemed panelists Dr. Shahnaz Sultan, Dr. Carol Peng, and Dr. Melanie Bird as they delve into the methodology behind the 2025 AACE Clinical Practice Guideline on Pharmacologic Management of Adults with Dyslipidemia. Discover insights into: Why AACE adopted the GRADE framework and its implications for guideline development. The critical role of systematic reviews in creating evidence-based recommendations. How evidence is assessed using the GRADE approach. Practical takeaways for clinicians when implementing GRADE-informed guidelines in patient care. Whether you’re a seasoned practitioner or new to the field, this discussion offers valuable perspectives on the evolution of evidence-based guideline development and its impact on clinical practice.

Showing 1–20 of 20 episodes